Long-chain free fatty acids (FFAs) are important metabolic substrates for energy production and lipid synthesis that are also involved in signaling processes (1, 2) . Two of the most common fatty acids in humans are the long-chain saturated FFA palmitate (C16:0) and the monounsaturated oleate (C18:1). Western diets rich in fatty acids are associated with increased levels of plasma cholesterol, hepatic steatosis, and a greater risk of cardiovascular disease (3, 4) . High levels of circulating FFAs, in particular of saturated FFAs, are implicated in insulin resistance and pancreatic b-cell dysfunction, and are predictive of diabetes development (5 -8) . In vitro exposure to high levels of FFAs leads to lipotoxicity, causing cellular dysfunction and death (5, 9) .
The low solubility of long-chain FFAs in aqueous solutions represents one of the major limitations for in vitro and in vivo studies. To overcome this problem, FFAs can be conjugated to albumin, allowing the preparation of solutions in the physiological concentration range. The fraction of unbound FFAs accessible for cellular uptake depends on the ratio of total FFAs to albumin (10) . Thus, the biological effect of FFAs can be augmented by increasing the FFA concentration or by decreasing the bovine serum albumin (BSA) concentration. The unbound FFA concentration is also determined by the relative affinities of the FFAs for albumin (10) . For example, when using a total FFA concentration of 0. Results represent mean ± SEM; *P < 0.05, **P < 0.01, and ***P < 0.001 compared to CTL.
ratio of 3.3, the theoretical unbound palmitate and oleate concentrations are 27 nM and 47 nM, respectively (11) .
Under normal physiological conditions, an average of 2 FFA molecules are bound to each albumin molecule in the circulation, corresponding to concentrations of unbound FFAs less than 20 nM. The FFA/albumin molar ratio can rise to as high as 6 in pathological conditions (12, 13) . In experimental systems designed to evaluate mechanisms of lipotoxicity relevant to pathophysiological states, variable and sometimes high molar ratios are used (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) . Ratios greater than 5 should be avoided as they may exceed FFA solubility, potentially inducing artifacts.
In spite of the crucial role of albumin in determining biologically available FFA levels, the BSA concentration or FFA/ albumin molar ratio are frequently not mentioned in scientific reports (24, 25) .
Albumin preparations may contain variable amounts of contaminants (26) , which can affect FFA binding. Charcoal treatment of BSA allows the removal of (E) ATF3 and (F) CHOP mRNA expression in human islets cultured 48 h in the absence (CTL) or presence of 0.5 mM palmitate (PAL) in medium containing 1% charcoal-absorbed BSA or 0.67% FFA-free BSA precomplexed to palmitate (n = 6). Gene expression was normalized for the geometric mean of the expression levels of reference genes GAPDH, b-actin, and OAZ1. For INS-1E cells, the normalized data were expressed as fold induction of CTL. Results represent mean ± SEM; *P < 0.05, **P < 0.01, and ***P < 0.001 for the comparison against CTL. Vol. 58 | No. 5 | 2015 some contaminants, including endogenous bovine FFAs (26) , and has been used by our group in previous publications (11, (27) (28) (29) (30) . FFA-free albumins are commercially available and have a high degree of purity. FFAs can be added directly to albumin-containing culture medium or be precomplexed with albumin before being added to the medium.
Here we present a systematic comparison of the effects of different preparations of palmitate or oleate and BSA on lipotoxicity in pancreatic b-cells. Charcoal-absorbed BSA and FFA-free BSA were used to prepare FFA solutions, as described in the Materials and methods section in the Supplementary Material. Compared with charcoal-absorbed BSA, FFA-free BSA has the advantage of having less residual FFAs bound to it. Exposure of INS-1E cells for 16 h to 0.5 mM palmitate in 1% FFA-free BSA-containing medium (FFA /albumin ratio of 3.3) induced significantly less apoptosis compared with medium containing 1% charcoalabsorbed BSA ( Figure 1A) . We therefore asked whether the serial filtration steps that follow the charcoal incubation of BSA affect the final albumin concentration of the medium. The BSA concentration in the 1% charcoalabsorbed BSA preparation was 25% lower compared with 1% FFA-free BSA (n = 3-4, P = 0.03). In keeping with this result, a reduction from 1% to 0.75% FFA-free BSA (FFA/albumin ratio of 4.4) resulted in apoptosis levels comparable to the 1% charcoal-absorbed BSA preparation ( Figure 1A ). We next prepared FFA solutions by precomplexing palmitate with FFA-free BSA before diluting it into the medium (see Materials and methods section in the Supplementary Material). Compared with FFA stock solutions prepared in ethanol that are typically not kept for more than a month, the FFA-albumin complexes can be prepared in large amounts and stored for several years at -20°C. Precomplexed palmitate (0.5 mM, 0.75% FFA-free BSA) induced less apoptosis compared with the equivalent non-precomplexed preparation ( Figure  1A ). Similar apoptosis levels were only reached when the BSA concentration was lowered to 0.67% (FFA/albumin ratio of 5.0) ( Figure 1A) . We hypothesized that during the precomplexing of FFAs to BSA, some of the FFAs form aggregates resulting in lower FFA concentrations.
Oleate (0.5 mM) used in the presence of 1% charcoal-absorbed BSA or 0.75% FFA-free BSA, or precomplexed oleate used in the presence of 0.67% FFA-free BSA, induced comparable levels of apoptosis ( Figure 1B ), in keeping with the palmitate data. We also compared cell death induced in human islets by precomplexed FFA preparations against 1% charcoal-absorbed BSA, as used in previous reports (28) (29) (30) . Because primary human islets are less susceptible to lipotoxicity than clonal rat INS-1E cells (29, 31, 32) , islet cell death was assessed after 72 h of exposure. As in INS-1E cells, a reduction in the amount of BSA to 0.67% resulted in similar levels of palmitate-or oleateinduced cell death (Figure 1, C and  D) . These data illustrate that doseresponse experiments are of value for determining suitable experimental conditions. Based on the cell death data, we chose 1% charcoal-absorbed BSA, 0.75% FFA-free BSA, or precomplexed FFAs in the presence of 0.67% FFA-free BSA for further signal transduction studies.
FFAs cause b-cell apoptosis via the induction of endoplasmic reticulum (ER) stress and activation of the mitochondrial pathway of cell death through up-regulation of pro-apoptotic BCL-2 proteins (29) . We compared the effect of dif ferent palmitate and oleate preparations on the induction of transcription factors that mediate the ER stress response, namely activating transcription factor 3 (ATF3), spliced Vol. 58 | No. 5 | 2015
X-box binding protein 1 (XBP1s) and C/EBP homologous protein (CHOP), as well as the proapoptotic BCL-2 family member death protein 5 (DP5; also known as harakiri). Exposure to palmitate using the different BSA preparations induced similar levels of ATF3, XBP1s, CHOP, and DP5 mRNA expression (Figure 2, A-D) , with somewhat greater induction for precomplexed palmitate. The activation of the PERK and IRE1 branches of the ER stress response and the induction of DP5 mRNA by oleate is milder compared with palmitate (28, 29) . Overall, gene expression was modified by oleate in a comparable manner across the different oleate/ BSA preparations (Figure 2 ). Human islets exposed to palmitate with 1% charcoal-absorbed or 0.67% FFA-free BSA showed a similar induction of ATF3 and CHOP mRNA expression ( Figure  2 , E and F). Taken together, the gene expression data are in keeping with the apoptosis findings.
The results obtained with different FFA and BSA preparations might be explained by changes in the unbound FFA concentrations. These concentrations can be theoretically calculated using the multiple stepwise equilibrium model (10, 11) , but more recently it has become possible to directly measure them using the fluorescent probe ADIFAB2, which is an acrylodan-derivatized intestinal fatty acid binding protein (33) . Increasing the concentration of FFA-free BSA in the medium resulted in decreased unbound concentrations of FFAs ( Figure 3A ) in a linear manner across the range of concentrations examined ( Figure 3B ). In keeping with the comparable cellular responses to FFAs (Figures 1 and 2 ), FFAs used in the presence of 1% charcoal-absorbed BSA, 0.75% FFA-free BSA, or precomplexed FFAs used in the presence of 0.67% FFA-free BSA resulted in similar unbound FFA concentrations, ~26 nM for palmitate and ~35 nM for oleate ( Figure 3A) . These data confirm that the FFA-BSA precomplexing process probably results in some loss of FFAs due to aggregation.
The measurement of unbound FFA concentrations allowed us to compare apoptosis induced by similar unbound concentrations of oleate (24.8 ± 1.4 nM) and palmitate (24.4 ± 1.0 nM) (n = 3-6, P = 0.9). As expected, the saturated FFA palmitate induced significantly more cell apoptosis (17 ± 3%) than unsaturated oleate (7 ± 1%) (n = 4, P < 0.001).
Because of the importance of the unbound FFA concentrations, the use of fetal bovine serum (FBS) in cell culture also deser ves consideration. FBS contains albumin and other FFA binding proteins, which will lower unbound FFA concentrations. The albumin concentration of FBS is ~2.5 g/dl. The use of 10% FBS in medium will increase the albumin concentration by 0.25%, which may significantly alter unbound FFA concentrations and cellular effects ( Figure 1A and Figure 3A) . The mixture of bovine FFAs present in FBS may also affect experimental results. The addition of unsaturated fatty acids is protective against palmitate, at least in part through modulation of the ER stress response (28) .
A n equimolar combination of palmitate and oleate (total concentration 0.5 mM) in medium containing 0.75% FFA-free BSA resulted in an unbound FFA concentration of 34 nM, a value close to that observed for oleate.
In conclusion, when using FFAs for in vitro experiments, the concentrations and preparation of FFAs and BSA should be carefully considered. Our results demonstrate that the source of albumin and the method of FFA conjugation affect the unbound FFA concentrations and, consequently, cellular outcomes. In publications using FFAs, the FFA and BSA concentrations and the FFA/albumin molar ratio need to be provided. In addition, we recommend measuring unbound FFA concentrations when using FFAs for in vitro experiments. 
